Predict your next investment

HEALTHCARE | Biotechnology
cardioxyl.com

See what CB Insights has to offer

Total Raised

$66.55M

Investors Count

5

Deal Terms

5

Cardioxyl Pharmaceuticals Funding, Cardioxyl Pharmaceuticals Valuation & Cardioxyl Pharmaceuticals Revenue

5 Fundings

Cardioxyl Pharmaceuticals's latest funding round was a Acquired for on November 2, 2015.

Cardioxyl Pharmaceuticals's valuation in November 2012 was $43.66M.

Cardioxyl Pharmaceuticals's latest post-money valuation is from November 2015.

Sign up for a free trial to see Cardioxyl Pharmaceuticals's valuations in November 2015, August 2010, August 2009, December 2006 and more.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

11/2/2015

Acquired

$99M

5

11/7/2012

Series B

$99M

$43.66M

10

8/20/2010

Series A - III

$99M

$99M

0

8/11/2009

Series A - II

$99M

$99M

0

12/6/2006

Series A

$99M

$99M

0

Date

11/2/2015

11/7/2012

8/20/2010

8/11/2009

12/6/2006

Round

Acquired

Series B

Series A - III

Series A - II

Series A

Amount

$99M

$99M

$99M

$99M

Investors

Valuation

$99M

$43.66M

$99M

$99M

$99M

Revenue

Sources

5

10

0

0

0

Cardioxyl Pharmaceuticals Deal Terms

5 Deal Terms

Cardioxyl Pharmaceuticals's deal structure is available for 5 funding rounds, including their Acquired from November 02, 2015.

Round

Acquired

Series B

Series A - III

Series A - II

Series A

Funding Date

$99M

$99M

$99M

$99M

$99M

Pre-Money Valuation

$99M

$99M

$99M

$99M

Post-Money Valuation

$99M

$99M

$99M

$99M

$99M

Amount Raised

$99M

$99M

$99M

$99M

Shares Authorized

Issuance Price

$99M

$99M

$99M

$99M

Dividend Rate

$99M

$99M

$99M

$99M

Liquidation Preferences

$99M

$99M

$99M

$99M

Liquidation Price

Participation

$99M

$99M

$99M

Conversion Price

Anti Dilution

$99M

$99M

$99M

$99M

General Voting

$99M

$99M

$99M

$99M

$99M

Board Voting

$99M

$99M

$99M

$99M

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Acquired

$99M

$99M

$99M

$99M

Series B

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

Series A - III

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

Series A - II

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

Series A

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

Cardioxyl Pharmaceuticals Investors

5 Investors

Cardioxyl Pharmaceuticals has 5 investors. Bristol-Myers Squibb invested in Cardioxyl Pharmaceuticals's Acquired funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

11/2/2015

11/2/2015

1
Acquired

Corporation

New York

00/00/0000

00/00/0000

New Enterprise Associates

Subscribe to see more

Subscribe to see more

Venture Capital

California

00/00/0000

00/00/0000

Aurora Funds

Subscribe to see more

Subscribe to see more

Venture Capital

North Carolina

00/00/0000

00/00/0000

OrbiMed Advisors

Subscribe to see more

Venture Capital

New York

00/00/0000

00/00/0000

Osage University Partners

Subscribe to see more

Venture Capital

Pennsylvania

First funding

11/2/2015

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Last Funding

11/2/2015

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Investor

New Enterprise Associates

Aurora Funds

OrbiMed Advisors

Osage University Partners

Rounds

1
Acquired

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Board Seats

Subscribe to see more

Subscribe to see more

Type

Corporation

Venture Capital

Venture Capital

Venture Capital

Venture Capital

Location

New York

California

North Carolina

New York

Pennsylvania

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.